1. Home
  2. LBRT vs SYRE Comparison

LBRT vs SYRE Comparison

Compare LBRT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Energy Inc.

LBRT

Liberty Energy Inc.

HOLD

Current Price

$18.58

Market Cap

3.0B

Sector

Energy

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$32.65

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRT
SYRE
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
LBRT
SYRE
Price
$18.58
$32.65
Analyst Decision
Buy
Strong Buy
Analyst Count
12
6
Target Price
$17.92
$56.50
AVG Volume (30 Days)
3.4M
859.1K
Earning Date
01-28-2026
11-04-2025
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
1.13
N/A
Revenue
$3,910,953,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.50
$10.91
52 Week High
$23.58
$35.31

Technical Indicators

Market Signals
Indicator
LBRT
SYRE
Relative Strength Index (RSI) 53.75 58.30
Support Level $16.61 $31.50
Resistance Level $18.99 $33.22
Average True Range (ATR) 0.84 1.39
MACD -0.10 -0.53
Stochastic Oscillator 44.43 32.68

Price Performance

Historical Comparison
LBRT
SYRE

About LBRT Liberty Energy Inc.

Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: